MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
ZSTK
ZeroStack Corp.
There isn't enough reported data to score ZSTK yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
ZSTK Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
ZSTK's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like ZSTK.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | โ |
| Current | 15x | $189 | โ |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
ZSTK PE Valuation
ZSTK has no meaningful PE right now: it lost money over the past year.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
ZSTK Forward outlook
There aren't enough analyst estimates for ZSTK to show an outlook.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the stronger earnings trend. Trailing diluted EPS is up 29% for MS versus ZSTK down 165%.
ZSTK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$390.51 | +$207.12 |
| Q2 2023 | -$471.89 | +$114.27 |
| Q1 2023 | -$466.10 | -$75.87 |
| Q4 2022 | -$528.95 | -$173.32 |
ZSTK is still losing money, but less than at its worst: $390.51 per share over the past year, against $597.63 at its worst in late 2022.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over ZSTK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over ZSTK on profitability, with a higher operating margin.
ZSTK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $13.7M | -7.7% |
| Q1 2026 | $7.3M | -38% |
| Q4 2025 | $9.4M | -30% |
| Q3 2025 | $9.7M | -22% |
| Q2 2025 | $14.8M | -5.7% |
| Q1 2025 | $11.8M | -35% |
| Q4 2024 | $13.3M | -26% |
| Q3 2024 | $12.5M | -28% |
ZSTK's revenue has slid since its 2023 peak: $14M last quarter, down 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -177% | -160 points |
| Q1 2026 | -861% | -853 points |
| Q4 2025 | -1596% | -1551 points |
| Q3 2025 | -34% | -3.9 points |
| Q2 2025 | -17% | +5.2 points |
| Q1 2025 | -8.3% | +5.5 points |
| Q4 2024 | -45% | -3.4 points |
| Q3 2024 | -30% | -27 points |
ZSTK's operating margin was โ177% last quarter, down 160 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS has the edge over ZSTK on cash flow, with more consistent year-over-year improvement.
ZSTK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $1.4M | +$4.3M |
| Q1 2026 | -$3.8M | -$1.1M |
| Q4 2025 | -$3.2M | -$1.8M |
| Q3 2025 | $91K | +$2.2M |
| Q2 2025 | -$3M | -$2.7M |
| Q1 2025 | -$2.8M | -$1.3M |
| Q4 2024 | -$1.3M | -$253K |
| Q3 2024 | -$2.1M | -510% |
ZSTK's free cash flow was โ$6M over the past year, against โ$9M the year before. Free cash flow isn't a meaningful measure for financial services companies like ZSTK.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
ZSTK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2023 | -0.9x | Net Cash |
ZSTK has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like ZSTK.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
ZSTK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.5 | Neutral |
| Stochastic | 11.0 | Oversold |
ZSTK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
ZSTK PE vs Financial Services Sector
ZSTK has no meaningful PE right now: it lost money over the past year.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over ZSTK on trend strength, trading above more of its moving averages.
ZSTK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.58 | 30% below |
| 20 week MA | $3.32 | 24% below |
| 50 week MA | $5.44 | 54% below |
| 100 week MA | $14.8 | 83% below |
| 200 week MA | $53.8 | 95% below |
ZSTK is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over ZSTK on returns for 2026, with the stronger performance.
ZSTK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $3,159.0 | $1,560.0 | -51% |
| 2022 | $1,560.0 | $189.5 | -88% |
| 2023 | $189.5 | $52.7 | -72% |
| 2024 | $52.7 | $39.8 | -24% |
| 2025 | $39.8 | $7.28 | -82% |
| 2026 YTD | $7.28 | $2.51 | -66% |
ZSTK has finished every year since 2021 lower, and it's down 66% so far in 2026.